Association of recalcitrant scabies infestation and bullous pemphigoid in an infant
SUPPLEMENTARY MATERIAL: 100
HTML: 17
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Dear Editor, In adults, bullous pemphigoid (BP) has been described in association with scabies. We here describe an infant with recalcitrant scabies who developed generalized BP as confirmed by serological and immunofluorescence studies. About four weeks after birth, an otherwise healthy non-vaccinated male infant was diagnosed with scabies. His parents and sister were diagnosed with scabies as well. [...]
Rozenblat M, Halaj A, Levi A, et al. Bullous pemphigoid and scabies: is there an association? J Drugs Dermatol 2022;21:1009-11.
Konishi N, Suzuki K, Tokura Y, et al. Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid. Acta Derm Venereol 2000;80:281-3. DOI: https://doi.org/10.1080/000155500750012171
Reis-Filho EG, Silva Tde A, Aguirre LH, Reis CM. Bullous pemphigoid in a 3-month-old infant: case report and literature review of this dermatosis in childhood. An Bras Dermatol 2013;88:961-5. DOI: https://doi.org/10.1590/abd1806-4841.20132378
Neri I, Greco A, Bassi A, et al. Bullous pemphigoid in infant post vaccination: myth or reality? Int J Immunopathol Pharmacol 2016;29:295-9.
Nanda A, Nanda M, Dvorak R, et al. Bullous pemphigoid (BP) in an infant complicated by tuberculous meningoencephalitis. Int J Dermatol 2007;46:964-6. DOI: https://doi.org/10.1111/j.1365-4632.2007.03194.x
van Beek N, Schmidt E. Autoimmune bullous diseases. In: Höger P, Kinsler V, Yan A (eds.). Harper’s Textbook of Pediatric Dermatology, 4th edition. Wiley-Blackwell, Chichester; 2020:868-97.
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.